Stealth BioTherapeutics Corp. Banner Image

Stealth BioTherapeutics Corp.

  • Ticker MITO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Stealth BioTherapeutics Corp. Logo Image
  • 51-200 Employees
  • Based in Newton, Massachusetts
Stealth BioTherapeutics Corp. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, found in nearly every cell in the body, are the body's main source of energy production and are critical for normal organ function. Dysfunctional mitochondria characterize aMore number of rare genetic diseases and are involved in many common age-related diseases, typically involving organ systems with high energy demands such as the heart, the eye, and the brain. They believe their lead product candidate, elamipretide, has the potential to treat both rare metabolic cardiomyopathies, such as Barth, Duchenne and Becker muscular dystrophies and Friedreich's ataxia, rare mitochondrial diseases entailing nuclear DNA mutations, such as POLG-related disorders, as well as ophthalmic diseases entailing mitochondrial dysfunction, such as dry age-related macular degeneration and Leber's hereditary optic neuropathy.
4.8 / 5.0 (61)

Stealth BioTherapeutics Corp. reports have an aggregate usefulness score of 4.8 based on 61 reviews.

Stealth BioTherapeutics Corp.

Most Recent Annual Report

Stealth BioTherapeutics Corp.
MOST RECENT 2021 Annual Report

Older/Archived Annual Reports

Stealth BioTherapeutics Corp. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!